Moors & Cabot’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$975K Buy
14,123
+7,248
+105% +$500K 0.05% 344
2025
Q1
$477K Buy
6,875
+663
+11% +$46K 0.02% 497
2024
Q4
$534K Sell
6,212
-780
-11% -$67.1K 0.03% 485
2024
Q3
$833K Buy
6,992
+10
+0.1% +$1.19K 0.04% 381
2024
Q2
$997K Sell
6,982
-65
-0.9% -$9.28K 0.05% 309
2024
Q1
$905K Buy
7,047
+1,600
+29% +$205K 0.05% 329
2023
Q4
$563K Sell
5,447
-503
-8% -$52K 0.04% 429
2023
Q3
$541K Buy
5,950
+510
+9% +$46.4K 0.04% 409
2023
Q2
$440K Buy
5,440
+746
+16% +$60.4K 0.03% 483
2023
Q1
$374K Sell
4,694
-100
-2% -$7.96K 0.03% 529
2022
Q4
$324K Sell
4,794
-406
-8% -$27.5K 0.02% 559
2022
Q3
$259K Sell
5,200
-296
-5% -$14.7K 0.02% 615
2022
Q2
$306K Buy
5,496
+284
+5% +$15.8K 0.02% 554
2022
Q1
$289K Sell
5,212
-16
-0.3% -$887 0.02% 640
2021
Q4
$293K Sell
5,228
-12,228
-70% -$685K 0.02% 645
2021
Q3
$836K Buy
17,456
+12,228
+234% +$586K 0.05% 313
2021
Q2
$219K Buy
+5,228
New +$219K 0.02% 703
2021
Q1
Sell
-7,228
Closed -$253K 786
2020
Q4
$253K Hold
7,228
0.02% 572
2020
Q3
$251K Sell
7,228
-110
-1% -$3.82K 0.02% 525
2020
Q2
$239K Buy
+7,338
New +$239K 0.03% 519
2018
Q1
Sell
-8,050
Closed -$216K 598
2017
Q4
$216K Buy
+8,050
New +$216K 0.03% 501
2016
Q3
Sell
-29,864
Closed -$802K 543
2016
Q2
$802K Sell
29,864
-470
-2% -$12.6K 0.14% 179
2016
Q1
$822K Sell
30,334
-12,866
-30% -$349K 0.15% 175
2015
Q4
$1.25M Sell
43,200
-4,830
-10% -$140K 0.23% 119
2015
Q3
$1.3M Buy
48,030
+4,700
+11% +$127K 0.24% 111
2015
Q2
$1.18M Buy
43,330
+100
+0.2% +$2.73K 0.19% 130
2015
Q1
$1.16M Sell
43,230
-1,550
-3% -$41.4K 0.19% 129
2014
Q4
$939K Buy
44,780
+150
+0.3% +$3.15K 0.16% 150
2014
Q3
$1.07M Sell
44,630
-2,630
-6% -$62.9K 0.18% 130
2014
Q2
$1.09M Buy
+47,260
New +$1.09M 0.18% 129